NCT00171808 - Letrozole in the Treatment of Advanced or Recurrent Hormone Receptor Positive Endometrial Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2005

Primary Completion Date

May 31, 2010

Conditions

Endometrial Cancer

Interventions

DRUG

Letrozole

Trial Locations (15)

Ebersberg, Germany, Celle

Heidelberg, Germany, Ebersberg

Novartis Investigative Site, Freiburg im Breisgau

Ebersberg, Germany, Hamburg

Novartis Investigative Site, Hamburg

Celle, Germany, Hanover

Tuebingen, Germany, Heidelberg

Novartis Investigative Site, Karlsruhe

Muenchen, Germany, Kiel

Muenchen, Germany, München

Novartis Investigative Site, München

Novartis Investigative Site, Oberaudorf

Novartis Investigative Site, Rostock

Novartis Investigative Site, Tübingen

Hannover, Germany, Wolfsburg